A detailed history of Prelude Capital Management, LLC transactions in Sensus Healthcare, Inc. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 10,778 shares of SRTS stock, worth $74,368. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,778
Previous 10,778 -0.0%
Holding current value
$74,368
Previous $62,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.93 - $7.05 $53,135 - $75,984
10,778 New
10,778 $62,000
Q4 2022

Feb 14, 2023

SELL
$5.91 - $14.28 $125,676 - $303,664
-21,265 Reduced 63.05%
12,460 $92,000
Q3 2022

Nov 14, 2022

BUY
$7.64 - $14.97 $257,659 - $504,863
33,725 New
33,725 $423,000

Others Institutions Holding SRTS

About Sensus Healthcare, Inc.


  • Ticker SRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 16,556,000
  • Market Cap $114M
  • Description
  • Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provide...
More about SRTS
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.